9–10 October 2018, Magee-Womens Research Summit; Pittsburgh, USA

9–10 October 2018, Magee-Womens Research Summit; Pittsburgh, USA

The Magee-Womens Research Summit will shape the national agenda on women’s health and deliver our future vision of women’s health to the world. The centrepiece of the summit will be the award of a $1 million prize for collaborative and transformative research within reproductive sciences.

As world leaders in women’s health, Magee is uniquely positioned to introduce a new approach on the global stage. As researchers, as physicians – and as mothers and daughters, fathers and sons – we at Magee are dedicated to transformative science in women’s health research for the good of all humankind.

The moment of greatest plasticity in life occurs in the first nine months before birth, and can define a person’s life for the next 90 years. Our “9-90″ research focuses on human life in these first nine months so we can predict and change the course of illnesses that can occur over a lifetime. By better understanding the “human blueprint,” we can alter the trajectory of a person’s life by predicting and even changing the course of a multitude of conditions.

Collectively with our colleagues in women’s health across the globe, our work will accelerate the pace of discovery and establish new benchmarks in every aspect of medical care all over the world.

Magee-Womens Research Institute
Women carry 100 per cent of our future. Our pioneering research in genomics, reproductive health, fertility and women’s wellness, means healthier women, healthier newborns and a healthier world.
Driven by research excellence, Magee-Womens Research Institute is committed to understanding and improving women’s health, from the cellular level, through conception to complete lifespans. Collaboration and global reach enable us to examine women’s health from all perspectives, resulting in breakthroughs for science and for society.

The summit agenda will explore issues surrounding pregnancy, aging, and disease development and progression, and includes sessions on maternal mortality and women’s health advocacy. Speakers include:

  • Diana Bianchi, M.D., director, Eunice Kennedy Shriver National Institute of Child Health and Human Development: The winner of three separate lifetime achievement awards, Bianchi is a widely recognized leader in the areas of noninvasive prenatal DNA screening and diagnosis, as well as the development of new therapies that can be given prenatally to treat genetic disorders.
  • Lee Hood, M.D., Ph.D., co-founder and chief strategy officer, Institute for Systems Biology; SVP and CSO, Providence St. Joseph Health: Hood is a world-renowned scientist, inventor, entrepreneur and visionary. His discoveries have permanently changed the course of biology and revolutionized the understanding of genetics, life and human health.
  • Jennifer Howse, Ph.D., former president, March of Dimes Foundation: A nationally known expert in maternal and child health, science, and philanthropy, Howse served as president of the March of Dimes Foundation for more than two decades, overseeing successful public health and advocacy campaigns in birth defects testing and prevention.
  • Dennis Lo, M.D., Ph.D., associate dean (research), Chinese University of Hong Kong Faculty of Medicine; director, Li Ka Shing Institute of Health Sciences: Lo’s discovery of fetal DNA in a mother’s plasma helped pioneer noninvasive prenatal testing for genetic diseases. His group also has created a genetic map of the fetus by analyzing tiny fragments of DNA floating in the blood of prenatal women.
  • Clay Marsh, M.D., vice president & executive dean for health sciences, West Virginia University: Marsh is a national leader in personalized medicine and in pulmonary and critical care medicine. He has concentrated his efforts in determining how to help individuals stay healthy and how to create ecosystems to make this easy. His research has focused on defining the underlying mechanisms that determine health and disease.
  • Marcia Stefanic, Ph.D., professor of medicine, Stanford Prevention Research Center; director, Stanford Women and Sex Differences in Medicine: Stefanic’s research focuses on chronic disease prevention in both men and women through physical activity, diet and weight control. Diseases include heart disease, cancer, osteoporosis and dementia.
  • Michelle Williams, Sc.D., dean of the faculty, T.H. Chan School of Public Health, Harvard University: An expert in reproductive and perinatal epidemiology, Williams’ research has deepened science’s understanding of placental abruption, gestational diabetes and preeclampsia.
The Magee Prize
The Magee Prize will recognise and reward breakthrough research in the field of women’s health that will change the face of humankind. Magee-Womens Research Institute will award $1 million to the research collaboration between Magee researchers and other researchers anywhere in the world that makes the most significant contribution to women’s health research.
9–10 October 2018
Magee-Womens Research Summit
Categories: EVENTS, OCTOBER 2018